FDA approves Boston's injectable GERD (gastroesophageal reflux disease) implant
This article was originally published in Clinica
Executive Summary
The US FDA has approved Boston Scientific's liquid polymer-based treatment for gastroesophageal reflux disease (GERD), a condition in which some of the stomach's contents - including acid - flows up into the oesophagus.